Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.70%
#2 Audiera Audiera +5.15%
#3 Wibx Wibx +3.22%
#4 Quack AI Quack AI +2.73%
#5 BOT BOT +2.51%
#6 TronBank TronBank +2.46%
#7 Status Status +2.14%
#8 Starpower Starpower +2.06%
#9 Wiki Cat Wiki Cat +2.02%
#10 Janction Janction +1.95%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Innstillinger
Språk
NORSK
Valuta
USD
Tema
RBC Bioscience Corporation RBC Bioscience Corporation

RBC Bioscience Corporation

6848
Rangering i aksjer #32479
RBC Bioscience Corporation is a firm dedicated to the research, development,... RBC Bioscience Corporation is a firm dedicated to the research, development, production, and sale of specialized reagents and advanced equipment. These products cater to the life sciences and molecular diagnostic sectors. Its market reach is extensive, covering Europe, the United States, Asia, Taiwan, Africa, and Australia. The company's diverse product line includes reagents tailored for molecular biomedical diagnostics and scientific research, alongside automated instruments for gene and nucleic acid extraction. It also provides a range of nucleic acid extraction kits and associated reagent tissues. Sales are primarily conducted through a global network of distributors. Established in 1995, RBC Bioscience Corporation maintains its headquarters in New Taipei City, Taiwan.
Aksjekurs
$0.69957862
Sist synkronisert: 2026-08-17
Markedsverdi
$9.99M
Endring (1 dag)
-0.90%
Endring (1 år)
18.37%
Land
TW
Handel RBC Bioscience Corporation (6848)

Kategori

Healthcare
P/S-forhold for RBC Bioscience Corporation (6848)
P/S-forhold per 2026 TTM: 0
Ifølge RBC Bioscience Corporation sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/S-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet et P/S-forhold på 0.
P/S-historikk for RBC Bioscience Corporation fra 2026 til 2026
P/S-forhold ved hvert års slutt
År P/S-forhold Endre
Ikke nok data for de angitte datoene.
P/S-forhold for lignende selskaper eller konkurrenter
Selskap P/S-forhold Forskjell i P/S-forhold Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE